September 4, 2020
Cardiff University has signed an agreement with Cytox to help the company develop a genetic risk assessment tool for Alzheimer’s disease. Under the licence, Oxford- and Manchester-based Cytox will access the University’s intellectual property (IP) regarding polygenic risk scoring algorithms for predicting the future onset of Alzheimer’s disease. Cytox will […]